Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yoichi Dotake"'
Autor:
Takahiro Matsuyama, Yuya Tomioka, Hiromi Matsuyama, Yusuke Kamenohara, Kengo Tanigawa, Yoichi Dotake, Yoko Hagihara, Koichi Takagi, Kentaro Machida, Hiromasa Inoue
Publikováno v:
Respirology Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Abstract Mepolizumab, a humanized anti‐IL‐5 monoclonal antibody used for severe asthma, results in a reduced rate of asthma exacerbation, improved lung function, reduced oral corticosteroid use, and improved quality of life. A 62‐year‐old man
Externí odkaz:
https://doaj.org/article/4055e8f316eb4d8d8a8f8e63e82e1c49
Autor:
Takahiro Matsuyama, Hiromi Matsuyama, Yoichi Dotake, Koichi Takagi, Kentaro Machida, Hiromasa Inoue
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
T helper type 2 cells (Th2 cells) and group 2 innate lymphoid cells (ILC2s) play an important role in the pathophysiology of asthma, including airway eosinophilic inflammation. ILC2s are activated by epithelial-derived cytokines [interleukin-25 (IL-2
Externí odkaz:
https://doaj.org/article/97b3eaf2cdda436e8d67ebc5ccbf36a9
Autor:
Takahiro Matsuyama, Kentaro Machida, Keiko Mizuno, Hiromi Matsuyama, Yoichi Dotake, Masahiro Shinmura, Koichi Takagi, Hiromasa Inoue
Publikováno v:
Biomolecules, Vol 13, Iss 6, p 893 (2023)
Asthma is a heterogeneous disease characterized by chronic airway inflammation. Group 2 innate lymphoid cells (ILC2) play an important role in the pathogenesis of asthma. ILC2s lack antigen-specific receptors and respond to epithelial-derived cytokin
Externí odkaz:
https://doaj.org/article/e3b5f952ba5a4a2fb9c6ebeaf37f230a